Japan Intellectual Property Rights: USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

Japan, Nov. 7 -- DECIPHERA PHARMACEUTICALS LLC has got intellectual property rights for 'USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA.' Other related details are as follows:

Application Number: JP,2023-173372

Category (FI): A61K31/4164,A61K31/196,A61K31/198,A61K31/506,A61K39/395@N,A61K31/4188,A61K31/519,A61K31/513,A61K31/337,A61K31/4745,A61K31/704,A61K33/243,A61K31/4375,A61P43/00,121,A61P35/00,A61K45/00,A61P35/02,A61P1/00,C07D233/90,C07J5/00,C07D519/04,C07D233/90@A,C07D401/04,C07D487/04,144,C07D475/08,C07D239/553@A,C07D305/14,C07D491/22,C07H15/252,...